E02.095

3 trials

Sponsors

Universidade Federal de São Paulo, Universidade Veiga de Almeida, Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da USP

Conditions

BiotherapicsFabry DiseaseRotator Cuff

Phase 2

Study to evaluate the safety, tolerability and efficacy parameters of the drug PRX-102 administered by intravenous infusion every 2 weeks for 12 weeks, to adult patients with Fabry disease

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da USPFabry Disease

Start: 2013-12-02Updated: 2025-10-27

Platelet-rich blood product or corticosteroid, which is better for treating partial shoulder injuries?

Active, not recruitingRBR-7jw7z2g

Universidade Federal de São PauloRotator Cuff

Start: 2025-03-01Updated: 2025-10-27

Unknown Phase

Evaluation of a biotherapeutic as an adjunct treatment for Chronic Periodontitis

RecruitingRBR-86fwwnn

Universidade Veiga de AlmeidaBiotherapics

Start: 2024-06-19Updated: 2025-10-27